
Comparative statistics by cancer registry
Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
(Bhopal, India, 1991-1995 cases followed-up until 2000)Click on cancer site (ICD-10 code) for comparison
Site | ICD-10 | No. of cases | Male | Female | Number of cases by age group | Relative survival by age group | ||||||||||||
5-year survival | 5-year survival | |||||||||||||||||
No. | Abs | Rel | No. | Abs | Rel | <45 | 45-54 | 55-64 | 65-74 | 75+ | <45 | 45-54 | 55-64 | 65-74 | 75+ | |||
C01-02 | Tongue | 127 | 112 | 8.9 | 10.3 | 15 | 13.3 | 14.4 | 16 | 29 | 43 | 27 | 12 | 44.9 | 7.4 | 8.2 | 0.0 | 0.0 |
C03-06 | Oral cavity | 172 | 110 | 30.0 | 34.7 | 62 | 27.4 | 31.5 | 20 | 57 | 43 | 39 | 13 | 61.5 | 35.5 | 40.5 | 14.1 | 0.0 |
C12-13 | Hypopharynx | 118 | 103 | 1.9 | 2.3 | 15 | 16 | 31 | 38 | 22 | 11 | 0.0 | 3.5 | 3.1 | 0.0 | 0.0 | ||
C15 | Oesophagus | 163 | 99 | 4.0 | 4.6 | 64 | 1.6 | 1.7 | 18 | 43 | 46 | 38 | 18 | 11.4 | 7.4 | 0.0 | 0.0 | 0.0 |
C16 | Stomach | 75 | 47 | 4.3 | 4.7 | 28 | 10 | 29 | 15 | 16 | 5 | 20.3 | 0.0 | 0.0 | 0.0 | 0.0 | ||
C18 | Colon | 48 | 31 | 6.5 | 7.4 | 17 | 5.9 | 6.2 | 8 | 14 | 14 | 8 | 4 | 12.7 | 15.1 | 0.0 | 0.0 | 0.0 |
C19-20 | Rectum | 39 | 21 | 4.8 | 5.4 | 18 | 11.1 | 11.7 | 7 | 10 | 15 | 6 | 1 | 14.6 | 10.5 | 7.8 | 0.0 | 0.0 |
C32 | Larynx | 60 | 51 | 5.9 | 6.9 | 9 | 11.1 | 12.6 | 5 | 15 | 30 | 6 | 4 | 20.6 | 0.0 | 3.9 | 44.2 | 0.0 |
C33-34 | Lung | 216 | 183 | 1.1 | 1.3 | 33 | 20 | 44 | 74 | 58 | 20 | 0.0 | 4.9 | 0.0 | 0.0 | 0.0 | ||
C50 | Breast | 261 | 3 | 66.7 | 75.1 | 258 | 30.2 | 32.3 | 80 | 90 | 61 | 22 | 8 | 44.5 | 29.0 | 35.1 | 5.9 | 0.0 |
C53 | Cervix | 332 | 332 | 33.1 | 35.4 | 114 | 109 | 70 | 30 | 9 | 51.7 | 33.5 | 20.8 | 17.9 | 0.0 | |||
C56 | Ovary | 69 | 69 | 18.8 | 20.1 | 29 | 18 | 13 | 7 | 2 | 28.0 | 17.3 | 8.7 | 22.9 | 0.0 | |||
C67 | Urinary bladder | 46 | 36 | 8.3 | 10.1 | 10 | 1 | 11 | 16 | 9 | 9 | 0.0 | 9.6 | 7.2 | 15.4 | 0.0 | ||
C82-85+C96 | Non-Hodgkin lymphoma | 30 | 25 | 5 | 60.0 | 61.5 | 12 | 9 | 6 | 3 | 0 | 16.9 | 11.7 | 0.0 | 0.0 | 0.0 | ||
C91 | Lymphoid leukaemia | 32 | 27 | 14.8 | 15.5 | 5 | 25 | 2 | 3 | 1 | 1 | 12.2 | 0.0 | 39.2 | 0.0 | 0.0 | ||
C92-94 | Myeloid leukaemia | 75 | 50 | 14.0 | 14.5 | 25 | 20.0 | 21.2 | 54 | 10 | 8 | 1 | 2 | 18.8 | 10.7 | 14.1 | 0.0 | 0.0 |
Graphs:
Other tables available for this registry:
- Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
- Table2b: | Number and proportion of cases by vital status and median follow-up (in months) by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
- Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
- Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Bhopal, India, 1991-1995 cases followed-up until 2000) |
- Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Bhopal, India, 1991-1995) |
Registry chapter:
![]() | Consult the chapter in Cancer survival in developping countries (Volume II) |